-
1
-
-
84893257773
-
-
(World Health Organization)
-
World Health Organization. Global Tuberculosis Report (World Health Organization, 2015).
-
(2015)
Global Tuberculosis Report
-
-
-
2
-
-
84867115232
-
Social determinants of tuberculosis in Europe: A prospective ecological study
-
Ploubidis, G. B. et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur. Respir. J. 40, 925-930 (2012).
-
(2012)
Eur. Respir. J.
, vol.40
, pp. 925-930
-
-
Ploubidis, G.B.1
-
3
-
-
84905397869
-
Individual and social vulnerabilities upon acquiring tuberculosis: A literature systematic review
-
Nadjane Batista Lacerda, S. et al. Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int. Arch. Med. 7, 35-35 (2014).
-
(2014)
Int. Arch. Med.
, vol.7
, pp. 35
-
-
Nadjane Batista-Lacerda, S.1
-
4
-
-
84871599953
-
HIV-1 and the immune response to TB
-
Walker, N. F., Meintjes, G. & Wilkinson, R. J. HIV-1 and the immune response to TB. Future Virol. 8, 57-80 (2013).
-
(2013)
Future Virol.
, vol.8
, pp. 57-80
-
-
Walker, N.F.1
Meintjes, G.2
Wilkinson, R.J.3
-
5
-
-
84947037645
-
Causes of hospital admission among people living with HIV worldwide: A systematic review and meta-analysis
-
Ford, N. et al. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2, e438-e444 (2015).
-
(2015)
Lancet HIV
, vol.2
, pp. e438-e444
-
-
Ford, N.1
-
6
-
-
80053084687
-
The burden of TB-HIV in the EU: How much do we know? A survey of surveillance practices and results
-
Kruijshaar, M. E. et al. The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. Eur. Respir. J. 38, 1374-1381 (2011).
-
(2011)
Eur. Respir. J.
, vol.38
, pp. 1374-1381
-
-
Kruijshaar, M.E.1
-
7
-
-
84906046594
-
Delivering TB/HIV services in Ghana: A comparative study of service delivery models
-
Ansa, G. A., Walley, J. D., Siddiqi, K. & Wei, X. Delivering TB/HIV services in Ghana: a comparative study of service delivery models. Trans. R. Soc. Trop. Med. Hyg. 108, 560-567 (2014).
-
(2014)
Trans. R. Soc. Trop. Med. Hyg.
, vol.108
, pp. 560-567
-
-
Ansa, G.A.1
Walley, J.D.2
Siddiqi, K.3
Wei, X.4
-
8
-
-
84891619248
-
Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa
-
Uyei, J., Coetzee, D., Macinko, J., Weinberg, S. L. & Guttmacher, S. Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa. Health Policy Plan. 29, 42-55 (2014).
-
(2014)
Health Policy Plan.
, vol.29
, pp. 42-55
-
-
Uyei, J.1
Coetzee, D.2
Macinko, J.3
Weinberg, S.L.4
Guttmacher, S.5
-
9
-
-
84866078656
-
PEPFAR support for the scaling up of collaborative TB/HIV activities
-
Howard, A. A. et al. PEPFAR support for the scaling up of collaborative TB/HIV activities. J. Acquir. Immune Defic. Syndr. 60(Suppl 3): S136-S144 (2012).
-
(2012)
J. Acquir. Immune Defic. Syndr.
, vol.60
, pp. S136-S144
-
-
Howard, A.A.1
-
10
-
-
84901488729
-
Scaling up intensified tuberculosis case finding in HIV clinics in Rwanda
-
Uwinkindi, F. et al. Scaling up intensified tuberculosis case finding in HIV clinics in Rwanda. J. Acquir. Immune Defic. Syndr. 66, e45-e49 (2014).
-
(2014)
J. Acquir. Immune Defic. Syndr.
, vol.66
, pp. e45-e49
-
-
Uwinkindi, F.1
-
11
-
-
84872698280
-
Integrating tuberculosis and HIV services in low- and middle-income countries: A systematic review
-
Legido-Quigley, H. et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop. Med. Int. Health 18, 199-211 (2013).
-
(2013)
Trop. Med. Int. Health
, vol.18
, pp. 199-211
-
-
Legido-Quigley, H.1
-
12
-
-
79955657437
-
Tuberculosis and noncommunicable diseases: Neglected links and missed opportunities
-
Creswell, J. et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur. Respir. J. 37, 1269-1282 (2011).
-
(2011)
Eur. Respir. J.
, vol.37
, pp. 1269-1282
-
-
Creswell, J.1
-
13
-
-
84859215760
-
Risk factors associated with pulmonary tuberculosis: Smoking, diabetes and anti-TNFalpha drugs
-
Ferrara, G. et al. Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFalpha drugs. Curr. Opin. Pulm. Med. 18, 233-240 (2012).
-
(2012)
Curr. Opin. Pulm. Med.
, vol.18
, pp. 233-240
-
-
Ferrara, G.1
-
14
-
-
84871781313
-
History of tuberculosis and drug resistance
-
Sotgiu, G., Spanevello, A. & Migliori, G. B. History of tuberculosis and drug resistance. N. Engl. J. Med. 368, 88-89 (2013).
-
(2013)
N. Engl. J. Med.
, vol.368
, pp. 88-89
-
-
Sotgiu, G.1
Spanevello, A.2
Migliori, G.B.3
-
15
-
-
84876927696
-
Challenges to the global control of tuberculosis
-
Chiang, C. Y., Van Weezenbeek, C., Mori, T. & Enarson, D. A. Challenges to the global control of tuberculosis. Respirology 18, 596-604 (2013).
-
(2013)
Respirology
, vol.18
, pp. 596-604
-
-
Chiang, C.Y.1
Van Weezenbeek, C.2
Mori, T.3
Enarson, D.A.4
-
16
-
-
84920584733
-
Multidrug-resistant tuberculosis around the world: What progress has been made?
-
Falzon, D. et al. Multidrug-resistant tuberculosis around the world: what progress has been made? Eur. Respir. J. 45, 150-160 (2015).
-
(2015)
Eur. Respir. J.
, vol.45
, pp. 150-160
-
-
Falzon, D.1
-
17
-
-
84943541115
-
Shifting to sustainable development goals-implications for global health
-
Murray, C. J. L. Shifting to sustainable development goals-implications for global health. N. Engl. J. Med. 373, 1390-1393 (2015).
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 1390-1393
-
-
Murray, C.J.L.1
-
18
-
-
84949498536
-
Stopping tuberculosis: A biosocial model for sustainable development
-
Ortblad, K. F., Salomon, J. A., Barnighausen, T. & Atun, R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet 386, 2354-2362 (2015).
-
(2015)
Lancet
, vol.386
, pp. 2354-2362
-
-
Ortblad, K.F.1
Salomon, J.A.2
Barnighausen, T.3
Atun, R.4
-
19
-
-
84929032442
-
WHO's new end TB strategy
-
Uplekar, M. et al. WHO's new end TB strategy. Lancet 385, 1799-1801 (2015).
-
(2015)
Lancet
, vol.385
, pp. 1799-1801
-
-
Uplekar, M.1
-
20
-
-
60449119706
-
Reflections on the white plague
-
Zumla, A. et al. Reflections on the white plague. Lancet Infect. Dis. 9, 197-202 (2009).
-
(2009)
Lancet Infect. Dis.
, vol.9
, pp. 197-202
-
-
Zumla, A.1
-
21
-
-
0003878012
-
-
(World Health Organization)
-
World Health Organization. TB: a Global Emergency, WHO Report on the TB Epidemic. (World Health Organization, 1994). Available at http://apps.who.int/iris/handle/10665/58749#sthash.trpE3VaC.dpuf.
-
(1994)
TB: A Global Emergency, WHO Report on the TB Epidemic
-
-
-
23
-
-
20144370344
-
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
-
Dye, C., Watt, C. J., Bleed, D. M., Hosseini, S. M. & Raviglione, M. C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293, 2767-2775 (2005).
-
(2005)
JAMA
, vol.293
, pp. 2767-2775
-
-
Dye, C.1
Watt, C.J.2
Bleed, D.M.3
Hosseini, S.M.4
Raviglione, M.C.5
-
24
-
-
33645016204
-
WHO's new stop TB strategy
-
Raviglione, M. C. & Uplekar, M. W. WHO's new Stop TB Strategy. Lancet 367, 952-955 (2006).
-
(2006)
Lancet
, vol.367
, pp. 952-955
-
-
Raviglione, M.C.1
Uplekar, M.W.2
-
25
-
-
84943428817
-
Translating the tuberculosis research agenda: Much accomplished, but much more to be done
-
Schito, M., Maeurer, M., Kim, P., Hanna, D. & Zumla, A. Translating the Tuberculosis Research Agenda: much accomplished, but much more to be done. Clin. Infect. Dis. 61, S95-S101 (2015).
-
(2015)
Clin. Infect. Dis.
, vol.61
, pp. S95-S101
-
-
Schito, M.1
Maeurer, M.2
Kim, P.3
Hanna, D.4
Zumla, A.5
-
26
-
-
84922970030
-
Towards tuberculosis elimination: An action framework for low-incidence countries
-
Lönnroth, K. et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur. Respir. J. 45, 928-952 (2015).
-
(2015)
Eur. Respir. J.
, vol.45
, pp. 928-952
-
-
Lönnroth, K.1
-
27
-
-
84880142045
-
Old ideas to innovate tuberculosis control: Preventive treatment to achieve elimination
-
Diel, R. et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur. Respir. J. 42, 785-801 (2013).
-
(2013)
Eur. Respir. J.
, vol.42
, pp. 785-801
-
-
Diel, R.1
-
28
-
-
84896477367
-
Tuberculosis elimination: Theory and practice in Europe
-
D'Ambrosio, L. et al. Tuberculosis elimination: theory and practice in Europe. Eur. Respir. J. 43, 1410-1420 (2014).
-
(2014)
Eur. Respir. J.
, vol.43
, pp. 1410-1420
-
-
D'Ambrosio, L.1
-
29
-
-
84949035058
-
Management of latent mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
-
Getahun, H. et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur. Respir. J. 46, 1563-1576 (2015).
-
(2015)
Eur. Respir. J.
, vol.46
, pp. 1563-1576
-
-
Getahun, H.1
-
30
-
-
84860337632
-
European union standards for tuberculosis care
-
Migliori, G. B. et al. European union standards for tuberculosis care. Eur. Respir. J. 39, 807-819 (2012).
-
(2012)
Eur. Respir. J.
, vol.39
, pp. 807-819
-
-
Migliori, G.B.1
-
33
-
-
46349101177
-
Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum
-
Marais, B. J. et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin. Infect. Dis. 47, 203-207 (2008).
-
(2008)
Clin. Infect. Dis.
, vol.47
, pp. 203-207
-
-
Marais, B.J.1
-
36
-
-
84956698324
-
Implementing the xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: Outcomes and lessons learned in 18 countries
-
Ardizzoni, E. et al. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS ONE 10, e0144656 (2015).
-
(2015)
PLoS ONE
, vol.10
, pp. e0144656
-
-
Ardizzoni, E.1
-
37
-
-
84862205633
-
Clinical validation of xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
-
Tortoli, E. et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 40, 442-447 (2012).
-
(2012)
Eur. Respir. J.
, vol.40
, pp. 442-447
-
-
Tortoli, E.1
-
38
-
-
84880151052
-
Rapid molecular TB diagnosis: Evidence, policy making and global implementation of xpert MTB/RIF
-
Weyer, K. et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur. Respir. J. 42, 252-271 (2013).
-
(2013)
Eur. Respir. J.
, vol.42
, pp. 252-271
-
-
Weyer, K.1
-
39
-
-
84925248470
-
Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
-
Steingart, K. R. et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1, CD009593 (2014).
-
(2014)
Cochrane Database Syst. Rev.
, vol.1
, pp. CD009593
-
-
Steingart, K.R.1
-
40
-
-
84938100016
-
A novel solid medium for culturing mycobacterium tuberculosis isolates from clinical specimens
-
Asmar, S. et al. A novel solid medium for culturing mycobacterium tuberculosis isolates from clinical specimens. J. Clin. Microbiol. 53, 2566-2569 (2015).
-
(2015)
J. Clin. Microbiol.
, vol.53
, pp. 2566-2569
-
-
Asmar, S.1
-
41
-
-
48749127726
-
Geno type MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis
-
Ling, D. I., Zwerling, A. A. & Pai, M. Geno Type MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32, 1165-1174 (2008).
-
(2008)
Eur. Respir. J.
, vol.32
, pp. 1165-1174
-
-
Ling, D.I.1
Zwerling, A.A.2
Pai, M.3
-
42
-
-
84940054531
-
Diagnostic performance of the new version (v2.0) of geno type MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: A multicenter study
-
Tagliani, E. et al. Diagnostic performance of the new version (v2.0) of Geno Type MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study. J. Clin. Microbiol. 53, 2961-2969 (2015).
-
(2015)
J. Clin. Microbiol.
, vol.53
, pp. 2961-2969
-
-
Tagliani, E.1
-
44
-
-
84942192606
-
Whole-genome sequencing for prediction of mycobacterium tuberculosis drug susceptibility and resistance: A retrospective cohort study
-
Walker, T. M. et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect. Dis. 15, 1193-1202 (2015).
-
(2015)
Lancet Infect. Dis.
, vol.15
, pp. 1193-1202
-
-
Walker, T.M.1
-
45
-
-
84929994231
-
Defining the needs for next generation assays for tuberculosis
-
Denkinger, C. M. et al. Defining the needs for next generation assays for tuberculosis. J. Infect. Dis. 211(Suppl 2): S29-S38 (2015).
-
(2015)
J. Infect. Dis.
, vol.211
, pp. S29-S38
-
-
Denkinger, C.M.1
-
46
-
-
84959112161
-
Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe
-
Zijenah, L. S. et al. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe. BMC Infect. Dis. 16, 20 (2016).
-
(2016)
BMC Infect. Dis.
, vol.16
, pp. 20
-
-
Zijenah, L.S.1
-
47
-
-
84942811235
-
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania
-
Kroidl, I. et al. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Eur. Respir. J. 46, 761-770 (2015).
-
(2015)
Eur. Respir. J.
, vol.46
, pp. 761-770
-
-
Kroidl, I.1
-
48
-
-
84922395137
-
Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults
-
Nakiyingi, L. et al. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J. Acquir. Immune Defic. Syndr. 66, 270-279 (2014).
-
(2014)
J. Acquir. Immune Defic. Syndr.
, vol.66
, pp. 270-279
-
-
Nakiyingi, L.1
-
50
-
-
84862003214
-
Point-of-care breath test for biomarkers of active pulmonary tuberculosis
-
Phillips, M. et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis 92, 314-320 (2012).
-
(2012)
Tuberculosis
, vol.92
, pp. 314-320
-
-
Phillips, M.1
-
53
-
-
84880162469
-
Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes
-
Falzon, D. et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur. Respir. J. 42, 56-168 (2013).
-
(2013)
Eur. Respir. J.
, vol.42
, pp. 56-168
-
-
Falzon, D.1
-
54
-
-
84880158505
-
Drug resistance beyond extensively drug-resistant tuberculosis: Individual patient data meta-analysis
-
Migliori, G. B. et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur. Respir. J. 42, 169-179 (2013).
-
(2013)
Eur. Respir. J.
, vol.42
, pp. 169-179
-
-
Migliori, G.B.1
-
56
-
-
84943258775
-
Classification of antituberculosis drugs: A new proposal based on the most recent evidence
-
Caminero, J. A. & Scardigli, A. Classification of antituberculosis drugs: a new proposal based on the most recent evidence. Eur. Respir. J. 46, 887-893 (2015).
-
(2015)
Eur. Respir. J.
, vol.46
, pp. 887-893
-
-
Caminero, J.A.1
Scardigli, A.2
-
57
-
-
85015466776
-
Short-course treatment for multidrug-resistant tuberculosis: The STREAM trials
-
Moodley, R. & Godec, T. R. Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials. Eur. Respir. Rev. 25, 29-35 (2016).
-
(2016)
Eur. Respir. Rev.
, vol.25
, pp. 29-35
-
-
Moodley, R.1
Godec, T.R.2
-
58
-
-
84928888056
-
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
-
Kuaban, C. et al. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon. Int. J. Tuberc. Lung Dis. 19, 517-524 (2015).
-
(2015)
Int. J. Tuberc. Lung Dis.
, vol.19
, pp. 517-524
-
-
Kuaban, C.1
-
59
-
-
84907033159
-
High cure rate with standardised short-course multidrugresistant tuberculosis treatment in Niger: No relapses
-
Piubello, A. et al. High cure rate with standardised short-course multidrugresistant tuberculosis treatment in Niger: no relapses. Int. J. Tuberc. Lung Dis. 18, 1188-1194 (2014).
-
(2014)
Int. J. Tuberc. Lung Dis.
, vol.18
, pp. 1188-1194
-
-
Piubello, A.1
-
60
-
-
84863490825
-
Tuberculosis: Cost of illness in Germany
-
Diel, R., Rutz, S., Castell, S. & Schaberg, T. Tuberculosis: cost of illness in Germany. Eur. Respir. J. 40, 143-151 (2012).
-
(2012)
Eur. Respir. J.
, vol.40
, pp. 143-151
-
-
Diel, R.1
Rutz, S.2
Castell, S.3
Schaberg, T.4
-
61
-
-
84893513006
-
Costs of tuberculosis disease in the european union: A systematic analysis and cost calculation
-
Diel, R. et al. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur. Respir. J. 43, 554-565 (2014).
-
(2014)
Eur. Respir. J.
, vol.43
, pp. 554-565
-
-
Diel, R.1
-
62
-
-
84975042205
-
WHO recommendations on shorter treatment of multidrugresistant tuberculosis
-
Sotgiu, G. et al. WHO recommendations on shorter treatment of multidrugresistant tuberculosis. Lancet 387, 2486-2487 (2016).
-
(2016)
Lancet
, vol.387
, pp. 2486-2487
-
-
Sotgiu, G.1
-
63
-
-
84942104576
-
Compassionate and optimum use of new tuberculosis drugs
-
Matteelli, A., D'Ambrosio, L., Centis, R., Tadolini, M. & Migliori, G. B. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect. Dis. 15, 1131-1132 (2015).
-
(2015)
Lancet Infect. Dis.
, vol.15
, pp. 1131-1132
-
-
Matteelli, A.1
D'Ambrosio, L.2
Centis, R.3
Tadolini, M.4
Migliori, G.B.5
-
64
-
-
84958093367
-
Bedaquiline and multidrug-resistant tuberculosis: A systematic and critical analysis of the evidence
-
Pontali, E., Sotgiu, G., D'Ambrosio, L., Centis, R. & Migliori, G. B. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence. Eur. Respir. J. 47, 394-402 (2016).
-
(2016)
Eur. Respir. J.
, vol.47
, pp. 394-402
-
-
Pontali, E.1
Sotgiu, G.2
D'Ambrosio, L.3
Centis, R.4
Migliori, G.B.5
-
65
-
-
84958073475
-
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
-
Pym, A. S. et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur. Respir. J. 47, 564-574 (2016).
-
(2016)
Eur. Respir. J.
, vol.47
, pp. 564-574
-
-
Pym, A.S.1
-
66
-
-
84923009815
-
Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis
-
Sotgiu, G., Pontali, E., Centis, R., D'Ambrosio, L. & Migliori, G. B. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis. Expert Rev. Anti Infect. Ther. 13, 305-315 (2015).
-
(2015)
Expert Rev. Anti Infect. Ther.
, vol.13
, pp. 305-315
-
-
Sotgiu, G.1
Pontali, E.2
Centis, R.3
D'Ambrosio, L.4
Migliori, G.B.5
-
69
-
-
84964054940
-
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
-
Tiberi, S. et al. Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB. Eur. Respir. J. 47, 1235-1243 (2016).
-
(2016)
Eur. Respir. J.
, vol.47
, pp. 1235-1243
-
-
Tiberi, S.1
-
70
-
-
84966692560
-
Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus obr control regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis
-
Tiberi, S. et al. Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus obr control regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. Clin. Infect. Dis. 62, 1188-1190 (2016).
-
(2016)
Clin. Infect. Dis.
, vol.62
, pp. 1188-1190
-
-
Tiberi, S.1
-
71
-
-
84973466840
-
Comparison of effectiveness and safety of imipenem/clavulanateversus meropenem/clavulanate-containing regimens in the treatment of MDRand XDR-TB
-
Tiberi, S. et al. Comparison of effectiveness and safety of imipenem/clavulanateversus meropenem/clavulanate-containing regimens in the treatment of MDRand XDR-TB. Eur. Respir. J. 47, 1758-1766 (2016).
-
(2016)
Eur. Respir. J.
, vol.47
, pp. 1758-1766
-
-
Tiberi, S.1
-
72
-
-
84954287886
-
Ertapenem in the treatment of multidrug-resistant tuberculosis: First clinical experience
-
Tiberi, S. et al. Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience. Eur. Respir. J. 47, 333-336 (2016).
-
(2016)
Eur. Respir. J.
, vol.47
, pp. 333-336
-
-
Tiberi, S.1
-
73
-
-
84920583395
-
Linezolid to treat MDR-/XDR-tuberculosis: Available evidence and future scenarios
-
Sotgiu, G., Pontali, E. & Migliori, G. B. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios. Eur. Respir. J. 45, 25-29 (2015).
-
(2015)
Eur. Respir. J.
, vol.45
, pp. 25-29
-
-
Sotgiu, G.1
Pontali, E.2
Migliori, G.B.3
-
74
-
-
84986182673
-
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively-drug resistant tuberculosis: Early experiences and challenges
-
Tadolini, M. et al. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively-drug resistant tuberculosis: early experiences and challenges. Eur. Respir. J. 48, 938-943 (2016).
-
(2016)
Eur. Respir. J.
, vol.48
, pp. 938-943
-
-
Tadolini, M.1
-
75
-
-
84906890048
-
ERS/WHO tuberculosis consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use
-
Esposito, S. et al. ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use. Eur. Respir. J. 44, 811-815 (2014).
-
(2014)
Eur. Respir. J.
, vol.44
, pp. 811-815
-
-
Esposito, S.1
-
76
-
-
84956964941
-
Recommendations for treating children with drug-resistant tuberculosis
-
Galli, L. et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol. Res. 105, 176-182 (2016).
-
(2016)
Pharmacol. Res.
, vol.105
, pp. 176-182
-
-
Galli, L.1
-
77
-
-
84986226612
-
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
-
in press
-
Tadolini, M. et al. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline. Eur. Respir. J. 48, 935-938, in press (2016).
-
(2016)
Eur. Respir. J.
, vol.48
, pp. 935-938
-
-
Tadolini, M.1
-
78
-
-
84959241751
-
Bedaquiline plus delamanid for XDR tuberculosis
-
Lachâtre, M. et al. Bedaquiline plus delamanid for XDR tuberculosis. Lancet Infect. Dis. 16, 294 (2016).
-
(2016)
Lancet Infect. Dis.
, vol.16
, pp. 294
-
-
Lachâtre, M.1
-
79
-
-
84942091323
-
Compassionate and optimum use of new tuberculosis drugs
-
Reed, C. et al. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect. Dis. 15, 1131 (2015).
-
(2015)
Lancet Infect. Dis.
, vol.15
, pp. 1131
-
-
Reed, C.1
-
80
-
-
84966656965
-
Therapeutic drug monitoring in anti-tuberculosis treatment: A systematic review and meta-analysis
-
Mota, L. et al. Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 20, 819-826 (2016).
-
(2016)
Int. J. Tuberc. Lung Dis.
, vol.20
, pp. 819-826
-
-
Mota, L.1
-
81
-
-
84925234402
-
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment
-
Sotgiu, G. et al. Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment. Int. J. Infect. Dis. 32, 101-104 (2015).
-
(2015)
Int. J. Infect. Dis.
, vol.32
, pp. 101-104
-
-
Sotgiu, G.1
-
82
-
-
84990938502
-
Official American thoracic society/Centers for disease control and Prevention/Infectious diseases society of america clinical practice guidelines: Treatment of drug-susceptible tuberculosis
-
Nahid, P. et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 63, e147-e195 (2016).
-
(2016)
Clin Infect Dis.
, vol.63
, pp. e147-e195
-
-
Nahid, P.1
-
83
-
-
84922192256
-
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
-
Daskapan, A. et al. The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection. Eur. Respir. J. 45, 569-571 (2015).
-
(2015)
Eur. Respir. J.
, vol.45
, pp. 569-571
-
-
Daskapan, A.1
-
84
-
-
84890108607
-
Therapeutic drug management: Is it the future of multidrug-resistant tuberculosis treatment?
-
Srivastava, S., Peloquin, C. A., Sotgiu, G. & Migliori, G. B. Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Eur. Respir. J. 42, 1449-1453 (2013).
-
(2013)
Eur. Respir. J.
, vol.42
, pp. 1449-1453
-
-
Srivastava, S.1
Peloquin, C.A.2
Sotgiu, G.3
Migliori, G.B.4
-
85
-
-
84922200165
-
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
-
Esposito, S., Codecasa, L. R. & Centis, R. The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection. Eur. Respir. J. 45, 571-574 (2015).
-
(2015)
Eur. Respir. J.
, vol.45
, pp. 571-574
-
-
Esposito, S.1
Codecasa, L.R.2
Centis, R.3
-
86
-
-
84864518733
-
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis
-
Sotgiu, G. et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur. Respir. J. 40, 1430-1442 (2012).
-
(2012)
Eur. Respir. J.
, vol.40
, pp. 1430-1442
-
-
Sotgiu, G.1
-
87
-
-
84962566015
-
Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
-
Wallis, R. S. et al. Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect. Dis. 16, e34-e46 (2016).
-
(2016)
Lancet Infect. Dis.
, vol.16
, pp. e34-e46
-
-
Wallis, R.S.1
-
88
-
-
84875255319
-
Supporting TB clinicians managing difficult cases: The ERS/WHO consilium
-
Blasi, F., Dara, M., van der Werf, M. J. & Migliori, G. B. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur. Respir. J. 41, 491-494 (2013).
-
(2013)
Eur. Respir. J.
, vol.41
, pp. 491-494
-
-
Blasi, F.1
Dara, M.2
Van Der-Werf, M.J.3
Migliori, G.B.4
-
90
-
-
80051511348
-
TB and M/XDR-TB infection control in european TB reference centres: The achilles' heel?
-
Sotgiu, G. et al. TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel? Eur. Respir. J. 38, 1221-1223 (2011).
-
(2011)
Eur. Respir. J.
, vol.38
, pp. 1221-1223
-
-
Sotgiu, G.1
-
91
-
-
84860345846
-
TB and MDR/XDR-TB in european union and european economic area countries: Managed or mismanaged?
-
Migliori, G. B. et al. TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Eur. Respir. J. 39, 619-625 (2012).
-
(2012)
Eur. Respir. J.
, vol.39
, pp. 619-625
-
-
Migliori, G.B.1
-
93
-
-
0033581124
-
Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project
-
Dye, C., Scheele, S., Dolin, P., Pathania & Raviglione, M. C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282, 677-686 (1999).
-
(1999)
JAMA
, vol.282
, pp. 677-686
-
-
Dye, C.1
Scheele, S.2
Dolin, P.3
Pathania4
Raviglione, M.C.5
-
94
-
-
84929846820
-
Latent mycobacterium tuberculosis infection
-
Getahun, H., Matteelli, A., Chaisson, R. E. & Raviglione, M. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 372, 2127-2135 (2015).
-
(2015)
N. Engl. J. Med.
, vol.372
, pp. 2127-2135
-
-
Getahun, H.1
Matteelli, A.2
Chaisson, R.E.3
Raviglione, M.4
-
97
-
-
84902064897
-
Childhood tuberculosis: A roadmap towards zero deaths
-
Marais, B. J. & Graham, S. M. Childhood tuberculosis: a roadmap towards zero deaths. J. Paediatr. Child Health 52, 258-261 (2016).
-
(2016)
J. Paediatr. Child Health
, vol.52
, pp. 258-261
-
-
Marais, B.J.1
Graham, S.M.2
-
98
-
-
2942731479
-
Treatment of latent tuberculosis infection in HIV infected persons
-
Akolo, C., Adetifa, I., Shepperd, S. & Volmink, J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst. Rev. 1, CD000171 (2010).
-
(2010)
Cochrane Database Syst. Rev.
, vol.1
, pp. CD000171
-
-
Akolo, C.1
Adetifa, I.2
Shepperd, S.3
Volmink, J.4
-
100
-
-
84963682933
-
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV
-
Den Boon, S., Matteelli, A., Ford, N. & Getahun, H. Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV. Aids 30, 797-801 (2016).
-
(2016)
AIDS
, vol.30
, pp. 797-801
-
-
Den Boon, S.1
Matteelli, A.2
Ford, N.3
Getahun, H.4
|